|
1
|
Forastiere AA, Trotti A, Pfister DG and
Grandis JR: Head and neck cancer: Recent advances and new standards
of care. J Clin Oncol. 24:2603–2605. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haddad RI and Shin DM: Recent advances in
head and neck cancer. N Engl J Med. 359:1143–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lo Nigro C, Denaro N, Merlotti A and
Merlano M: Head and neck cancer: Improving outcomes with a
multidisciplinary approach. Cancer Manag Res. 9:363–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khurshid Z, Zafar MS, Khan RS, Najeeb S,
Slowey PD and Rehman IU: Role of salivary biomarkers in oral cancer
detection. Adv Clin Chem. 86:23–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sahibzada HA, Khurshid Z, Khan RS, Naseem
M, Siddique KM, Mali M and Zafar MS: Salivary IL-8, IL-6 and TNF-α
as potential diagnostic biomarkers for oral cancer. Diagnostics
(Basel). 7:212017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dubiel W, Chaithongyot S, Dubiel D and
Naumann M: The COP9 signalosome: A multi-DUB complex. Biomolecules.
10:10822020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cavadini S, Fischer ES, Bunker RD, Potenza
A, Lingaraju GM, Goldie KN, Mohamed WI, Faty M, Petzold G, Beckwith
RE, et al: Cullin-RING ubiquitin E3 ligase regulation by the COP9
signalosome. Nature. 531:598–603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lingaraju GM, Bunker RD, Cavadini S, Hess
D, Hassiepen U, Renatus M, Fischer ES and Thomä NH: Crystal
structure of the human COP9 signalosome. Nature. 512:161–165. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin N, Xu D, Li J and Deng XW: COP9
signalosome: Discovery, conservation, activity, and function. J
Integr Plant Biol. 62:90–103. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao F, Lin H and Su Y: Cullin-RING ligase
regulation by the COP9 signalosome: Structural mechanisms and new
physiologic players. Adv Exp Med Biol. 1217:47–60. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ebina M, Tsuruta F, Katoh M, Kigoshi Y,
Someya A and Chiba T: Myeloma overexpressed 2 (Myeov2) regulates
L11 subnuclear localization through Nedd8 modification. PLoS One.
8:e652852013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L and Deng XW: The COP9 signalosome: An
alternative lid for the 26S proteasome? Trends Cell Biol.
13:507–509. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karniol B and Chamovitz DA: The COP9
signalosome: From light signaling to general developmental
regulation and back. Curr Opin Plant Biol. 3:387–393. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomoda K, Kubota Y and Kato J: Degradation
of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by
Jab1. Nature. 398:160–165. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bech-Otschir D, Kraft R, Huang X, Henklein
P, Kapelari B, Pollmann C and Dubiel W: COP9 signalosome-specific
phosphorylation targets p53 to degradation by the ubiquitin system.
EMBO J. 20:1630–1639. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim JH, Choi JK, Cinghu S, Jang JW, Lee
YS, Li YH, Goh YM, Chi XZ, Lee KS, Wee H and Bae SC: Jab1/CSN5
induces the cytoplasmic localization and degradation of RUNX3. J
Cell Biochem. 107:557–565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bemis L, Chan DA, Finkielstein CV, Qi L,
Sutphin PD, Chen X, Stenmark K, Giaccia AJ and Zundel W: Distinct
aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5.
Genes Dev. 18:739–744. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie P, Wang H, Fang J, Du D, Tian Z, Zhen
J, Liu Y, Ding Y, Fu B, Liu F, et al: CSN5 promotes carcinogenesis
of thyroid carcinoma cells through ANGPTL2. Endocrinology.
162:bqaa2062021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou J, Deng Q, Zhou J, Zou J, Zhang Y, Tan
P, Zhang W and Cui H: CSN6 controls the proliferation and
metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Oncogene. 36:1134–1144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su L, Guo W, Lou L, Nie S, Zhang Q, Liu Y,
Chang Y, Zhang X, Li Y and Shen H: EGFR-ERK pathway regulates CSN6
to contribute to PD-L1 expression in glioblastoma. Mol Carcinog.
59:520–532. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dubois EL, Gerber S, Kisselev A,
Harel-Bellan A and Groisman R: UV-dependent phosphorylation of
COP9/signalosome in UV-induced apoptosis. Oncol Rep. 35:3101–3105.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoneda-Kato N, Tomoda K, Umehara M, Arata
Y and Kato JY: Myeloid leukemia factor 1 regulates p53 by
suppressing COP1 via COP9 signalosome subunit 3. EMBO J.
24:1739–1749. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pollmann C, Huang X, Mall J, Bech-Otschir
D, Naumann M and Dubiel W: The constitutive photomorphogenesis 9
signalosome directs vascular endothelial growth factor production
in tumor cells. Cancer Res. 61:8416–8421. 2001.PubMed/NCBI
|
|
24
|
Denti S, Fernandez-Sanchez ME, Rogge L and
Bianchi E: The COP9 signalosome regulates Skp2 levels and
proliferation of human cells. J Biol Chem. 281:32188–32196. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee MH, Zhao R, Phan L and Yeung SC: Roles
of COP9 signalosome in cancer. Cell Cycle. 10:3057–3066. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang L, Wang J, Li J, Zhang H, Guo S, Yan
M, Zhu Z, Lan B, Ding Y, Xu M, et al: Identification of serum
biomarkers for gastric cancer diagnosis using a human proteome
microarray. Mol Cell Proteomics. 15:614–623. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan T, Wunder JS, Gokgoz N, Gill M,
Eskandarian S, Parkes RK, Bull SB, Bell RS and Andrulis IL: COPS3
amplification and clinical outcome in osteosarcoma. Cancer.
109:1870–1876. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong Y, Huang X, An L, Ye H, Ma K, Zhang F
and Xu Q: Overexpression of COPS3 promotes clear cell renal cell
carcinoma progression via regulation of Phospho-AKT(Thr308), cyclin
D1 and caspase-3. Exp Cell Res. 365:163–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun L: COPS8 in cutaneous melanoma: An
oncogene that accelerates the malignant development of tumor cells
and predicts poor prognosis. Biosci Biotechnol Biochem. 85:242–250.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reis PP, Waldron L, Perez-Ordonez B,
Pintilie M, Galloni NN, Xuan Y, Cervigne NK, Warner GC, Makitie AA,
Simpson C, et al: A gene signature in histologically normal
surgical margins is predictive of oral carcinoma recurrence. BMC
Cancer. 11:4372011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dodd LE, Sengupta S, Chen IH, den Boon JA,
Cheng YJ, Westra W, Newton MA, Mittl BF, McShane L, Chen CJ, et al:
Genes involved in DNA repair and nitrosamine metabolism and those
located on chromosome 14q32 are dysregulated in nasopharyngeal
carcinoma. Cancer Epidemiol Biomarkers Prev. 15:2216–2225. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schlingemann J, Habtemichael N, Ittrich C,
Toedt G, Kramer H, Hambek M, Knecht R, Lichter P, Stauber R and
Hahn M: Patient-based cross-platform comparison of oligonucleotide
microarray expression profiles. Lab Invest. 85:1024–1039. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cromer A, Carles A, Millon R, Ganguli G,
Chalmel F, Lemaire F, Young J, Dembélé D, Thibault C, Muller D, et
al: Identification of genes associated with tumorigenesis and
metastatic potential of hypopharyngeal cancer by microarray
analysis. Oncogene. 23:2484–2498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Toruner GA, Ulger C, Alkan M, Galante AT,
Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN
and Dermody JJ: Association between gene expression profile and
tumor invasion in oral squamous cell carcinoma. Cancer Genet
Cytogenet. 154:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ginos MA, Page GP, Michalowicz BS, Patel
KJ, Volker SE, Pambuccian SE, Ondrey FG, Adams GL and Gaffney PM:
Identification of a gene expression signature associated with
recurrent disease in squamous cell carcinoma of the head and neck.
Cancer Res. 64:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okuno T, Wakabayashi M, Kato K, Shinoda M,
Katayama H, Igaki H, Tsubosa Y, Kojima T, Okabe H, Kimura Y, et al:
Esophageal stenosis and the Glasgow Prognostic Score as independent
factors of poor prognosis for patients with locally advanced
unresectable esophageal cancer treated with chemoradiotherapy
(exploratory analysis of JCOG0303). Int J Clin Oncol. 22:1042–1049.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsherniak A, Vazquez F, Montgomery PG,
Weir BA, Kryukov G, Cowley GS, Gill S, Harrington WF, Pantel S,
Krill-Burger JM, et al: Defining a cancer dependency map. Cell.
170:564–576.e16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Irizarry RA, Wang C, Zhou Y and Speed TP:
Gene set enrichment analysis made simple. Stat Methods Med Res.
18:565–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wolf DA, Zhou C and Wee S: The COP9
signalosome: An assembly and maintenance platform for cullin
ubiquitin ligases? Nat Cell Biol. 5:1029–1033. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Füzesi-Levi MG, Fainer I, Ivanov Enchev R,
Ben-Nissan G, Levin Y, Kupervaser M, Friedlander G, Salame TM, Nevo
R, Peter M and Sharon M: CSNAP, the smallest CSN subunit, modulates
proteostasis through cullin-RING ubiquitin ligases. Cell Death
Differ. 27:984–998. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuroha K, Ando K, Nakagawa R and Inada T:
The Upf factor complex interacts with aberrant products derived
from mRNAs containing a premature termination codon and facilitates
their proteasomal degradation. J Biol Chem. 288:28630–28640. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wei N and Deng XW: The COP9 signalosome.
Annu Rev Cell Dev Biol. 19:261–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Adler AS, Lin M, Horlings H, Nuyten DS,
van de Vijver MJ and Chang HY: Genetic regulators of large-scale
transcriptional signatures in cancer. Nat Genet. 38:421–430. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sui L, Dong Y, Ohno M, Watanabe Y,
Sugimoto K, Tai Y and Tokuda M: Jab1 expression is associated with
inverse expression of p27(kip1) and poor prognosis in epithelial
ovarian tumors. Clin Cancer Res. 7:4130–4135. 2001.PubMed/NCBI
|
|
45
|
Sutterlüty H, Chatelain E, Marti A,
Wirbelauer C, Senften M, Müller U and Krek W: p45SKP2 promotes
p27Kip1 degradation and induces S phase in quiescent cells. Nat
Cell Biol. 1:207–214. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou BP, Liao Y, Xia W, Zou Y, Spohn B and
Hung MC: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2
phosphorylation. Nat Cell Biol. 3:973–982. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bernardi R, Scaglioni PP, Bergmann S, Horn
HF, Vousden KH and Pandolfi PP: PML regulates p53 stability by
sequestering Mdm2 to the nucleolus. Nat Cell Biol. 6:665–672. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Oh W, Lee EW, Sung YH, Yang MR, Ghim J,
Lee HW and Song J: Jab1 induces the cytoplasmic localization and
degradation of p53 in coordination with Hdm2. J Biol Chem.
281:17457–17465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao R, Yeung SC, Chen J, Iwakuma T, Su
CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, et al: Subunit 6 of the
COP9 signalosome promotes tumorigenesis in mice through
stabilization of MDM2 and is upregulated in human cancers. J Clin
Invest. 121:851–865. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ju S, Wang F, Wang Y and Ju S: CSN8 is a
key regulator in hypoxia-induced epithelial-mesenchymal transition
and dormancy of colorectal cancer cells. Mol Cancer. 19:1682020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yu YS, Tang ZH, Pan QC, Chen XH, Liu XN
and Zang GQ: Inhibition of Csn3 expression induces growth arrest
and apoptosis of hepatocellular carcinoma cells. Cancer Chemother
Pharmacol. 69:1173–1180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bhansali M and Shemshedini L: COP9
subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in
prostate cancer cells. Mol Endocrinol. 28:834–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yu TL, Cai DL, Zhu GF, Ye XJ, Min TS, Chen
HY, Lu DR and Chen HM: Effects of CSN4 knockdown on proliferation
and apoptosis of breast cancer MDA-MB-231 cells. Yi Chuan.
41:318–326. 2019.(In Chinese). PubMed/NCBI
|
|
54
|
Zhao S, Tang H, Yan D, Fan J, Sun H, Wen
Y, Yu F, Cui F, Zhang D, Xue Y, et al: DDA1 promotes stage IIB-IIC
colon cancer progression by activating NFκB/CSN2/GSK-3β signaling.
Oncotarget. 7:19794–19812. 2016. View Article : Google Scholar : PubMed/NCBI
|
